Can I read ELN2022 Risk Classification in AML HSCT on EtoBox?

ELN2022 Risk Classification in AML HSCT by Nuela Santiago is a document available to read on EtoBox.

What is ELN2022 Risk Classification in AML HSCT about?

This study retrospectively analyzed 522 patients with acute myeloid leukemia (AML) undergoing allogeneic stem cell transplantation to evaluate the prognostic impact of the ELN2022 risk classification. The findings indicated that while the ELN2022 classification is associated with outcomes such as relapse and survival, it did not significantly enhance prognostic predictions compared to the previous ELN2017 classification. Additionally, the study suggested that reclassifying patients with myelodysplasia-relat

Author

Nuela Santiago

Language

EN